TY - JOUR
T1 - Traditional and disease-related cardiovascular risk factors in ANCA-associated vasculitis
T2 - A prospective, two-centre cohort study
AU - Vegting, Yosta
AU - Penne, Erik L.
AU - Hilhorst, Marc L.
AU - Hoekstra, Tiny
AU - Bemelman, Frederike J.
AU - Vogt, Liffert
AU - Voskuyl, Alexandre E.
AU - Pagnoux, Christian
AU - Houben, Eline
N1 - Funding Information:
This work was supported by the Dutch Kidney Foundation [grant numbers 18OKK30 , 19OK007 ], Dutch Vasculitis Foundation, Northwest Academy [grant number INT/ae/201704076 ], and a research grant from CanVasc .
Publisher Copyright:
© 2023 The Author(s)
PY - 2023/7/1
Y1 - 2023/7/1
N2 - Objectives: ANCA-associated vasculitis (AAV) has been associated with increased risk of cardiovascular (CV) events. The aim was to assess traditional and disease-related CV risk determinants in a two-centre prospective cohort of AAV patients. Methods: Patients were recruited from centres in the Netherlands and Canada. A comprehensive CV risk assessment was performed at inclusion. Subjects were followed up yearly for 3–5 years until the first CV event, death or end of follow-up. Cox proportional hazards analyses were performed to relate baseline characteristics to the first CV event. Results: A total of 144 patients were included (mean age 62 years, female sex 44%, median Framingham risk score 14.3%). Insulin resistance was present in 73% of patients tested at inclusion, independent of concurrent prednisone therapy. After a median follow-up of 2.90 years, 16 patients (11%) experienced a CV event (14 non-fatal and 2 fatal). The incidence of CV events was 5.45 per 100 patient-years. Age, Framingham risk score, HbA1c level, Diabetes Mellitus (DM), and previous CV event were significantly associated with CV events. Other factors, such as sex, impaired renal function, dyslipidemia, hypertension, smoking history and microalbuminuria, or disease-specific variables, like ANCA serotype or disease activity, were not significantly related to CV events in univariable or age-adjusted cox regression analysis. Conclusions: Determinants of an increased CV risk were identified. Disease-related factors and treatments can further modify individual risk factors, such as for steroids causing chronic insulin resistance and DM. Treatment of risk factors is essential to optimize long-term outcomes in AAV patients.
AB - Objectives: ANCA-associated vasculitis (AAV) has been associated with increased risk of cardiovascular (CV) events. The aim was to assess traditional and disease-related CV risk determinants in a two-centre prospective cohort of AAV patients. Methods: Patients were recruited from centres in the Netherlands and Canada. A comprehensive CV risk assessment was performed at inclusion. Subjects were followed up yearly for 3–5 years until the first CV event, death or end of follow-up. Cox proportional hazards analyses were performed to relate baseline characteristics to the first CV event. Results: A total of 144 patients were included (mean age 62 years, female sex 44%, median Framingham risk score 14.3%). Insulin resistance was present in 73% of patients tested at inclusion, independent of concurrent prednisone therapy. After a median follow-up of 2.90 years, 16 patients (11%) experienced a CV event (14 non-fatal and 2 fatal). The incidence of CV events was 5.45 per 100 patient-years. Age, Framingham risk score, HbA1c level, Diabetes Mellitus (DM), and previous CV event were significantly associated with CV events. Other factors, such as sex, impaired renal function, dyslipidemia, hypertension, smoking history and microalbuminuria, or disease-specific variables, like ANCA serotype or disease activity, were not significantly related to CV events in univariable or age-adjusted cox regression analysis. Conclusions: Determinants of an increased CV risk were identified. Disease-related factors and treatments can further modify individual risk factors, such as for steroids causing chronic insulin resistance and DM. Treatment of risk factors is essential to optimize long-term outcomes in AAV patients.
KW - AAV
KW - ANCA-associated vasculitis
KW - Cardiovascular disease
KW - Diabetes mellitus
KW - HbA1c
KW - Risk factors
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85149783901&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/36758893
U2 - 10.1016/j.jbspin.2023.105540
DO - 10.1016/j.jbspin.2023.105540
M3 - Article
C2 - 36758893
SN - 1297-319X
VL - 90
JO - Joint Bone Spine
JF - Joint Bone Spine
IS - 4
M1 - 105540
ER -